Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to assess the safety of terbogrel during open-label, long-term treatment in medically
stable or improving patients with primary pulmonary hypertension who have completed the
12-week, double-blind randomized trial of terbogrel (protocol 528.19)